Anna Deda, Magdalena Hartman-Petrycka, Marta Gędoś, Martyna Wojciechowska, Dominika Wcisło-Dziadecka
Background: Acne vulgaris is a common inflammatory disorder with significant clinical and psychosocial impacts. Medium-depth chemical peels are increasingly used to manage both active acne lesions and atrophic acne scars. This study aimed to quantitatively assess the clinical effectiveness of a novel multimodal medium-depth chemical peel regimen, yellow peel, in improving acne severity and scar depth, as well as skin hydration and sebum production in patients with mild to moderate facial acne. Methods: Twenty patients (17 women and 3 men) aged 20-25 with mild to moderate acne vulgaris underwent two sessions of yellow peel treatment at four-week intervals. The peel protocol combined glycolic acid, salicylic acid, and a multi-acid mask containing retinol, azelaic, phytic, kojic, and salicylic acids. Clinical outcomes were evaluated at baseline, four weeks after the first peel, and two months after the second peel. Assessments included the Investigators Global Assessment (IGA), inflammatory lesion count, 3D scar depth analysis, skin hydration (corneometer), and sebum secretion (sebumeter). Results: Yellow peel treatment significantly reduced acne severity, with an 85% decrease in inflammatory lesion counts and over 20% reduction in scar depth. Skin hydration improved significantly across all facial regions, and sebum secretion decreased substantially, enhancing skin barrier function and seboregulation. Statistical analysis confirmed the treatment's efficacy with sustained improvements two months post-final peel. Conclusions: The yellow peel protocol is an effective and well-tolerated adjunct therapy for managing mild to moderate acne and atrophic acne scars. By combining exfoliative, anti-inflammatory, antibacterial, sebostatic, and depigmenting agents, this multimodal approach delivers comprehensive skin improvement. Further large-scale, controlled studies are recommended to confirm long-term safety and efficacy.
{"title":"Cosmetic Benefits of Medium-Depth Chemical Peels for Moderate Acne Lesions and Atrophic Acne Scars: A Single-Arm Clinical Trial in Young Adults.","authors":"Anna Deda, Magdalena Hartman-Petrycka, Marta Gędoś, Martyna Wojciechowska, Dominika Wcisło-Dziadecka","doi":"10.3390/jcm14238598","DOIUrl":"10.3390/jcm14238598","url":null,"abstract":"<p><p><b>Background:</b> Acne vulgaris is a common inflammatory disorder with significant clinical and psychosocial impacts. Medium-depth chemical peels are increasingly used to manage both active acne lesions and atrophic acne scars. This study aimed to quantitatively assess the clinical effectiveness of a novel multimodal medium-depth chemical peel regimen, yellow peel, in improving acne severity and scar depth, as well as skin hydration and sebum production in patients with mild to moderate facial acne. <b>Methods:</b> Twenty patients (17 women and 3 men) aged 20-25 with mild to moderate acne vulgaris underwent two sessions of yellow peel treatment at four-week intervals. The peel protocol combined glycolic acid, salicylic acid, and a multi-acid mask containing retinol, azelaic, phytic, kojic, and salicylic acids. Clinical outcomes were evaluated at baseline, four weeks after the first peel, and two months after the second peel. Assessments included the Investigators Global Assessment (IGA), inflammatory lesion count, 3D scar depth analysis, skin hydration (corneometer), and sebum secretion (sebumeter). <b>Results:</b> Yellow peel treatment significantly reduced acne severity, with an 85% decrease in inflammatory lesion counts and over 20% reduction in scar depth. Skin hydration improved significantly across all facial regions, and sebum secretion decreased substantially, enhancing skin barrier function and seboregulation. Statistical analysis confirmed the treatment's efficacy with sustained improvements two months post-final peel. <b>Conclusions:</b> The yellow peel protocol is an effective and well-tolerated adjunct therapy for managing mild to moderate acne and atrophic acne scars. By combining exfoliative, anti-inflammatory, antibacterial, sebostatic, and depigmenting agents, this multimodal approach delivers comprehensive skin improvement. Further large-scale, controlled studies are recommended to confirm long-term safety and efficacy.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 23","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12692859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Paweł Leyko, Monika Zaborska, Agnieszka Walczak, Łukasz Tomczyk, Marcin Pelc, Aleksander Mnich, Igor Kowal, Piotr Morasiewicz
Background: Biomechanical disorders may result from joint deformities. The purpose of this prospective research was to assess total load distribution over the lower limbs and balance in individuals before and after an hemiepiphysiodesis procedure performed due to valgus or varus knee deformity. Methods: Thirty-five patients, mean age 12 years, who underwent hemiphysiodesis for valgus or varus deformity of the knee were evaluated in comparison to a healthy control group. In patients, the percentage distribution of weight-bearing capacity between the operated and unoperated limbs was analyzed before and after surgery. Balance was assessed based on CoG (center of gravity) sway area and the CoG path length. Results were collected using the FreeMED MAXI pedobarographic platform. Results: Before surgery, statistically significant lower load on the entire affected limb was noted compared to unaffected limb. The values of path of center of gravity improved statistically significantly after surgery, compared to the values before surgery. There were no differences in the load on the treated lower limb in the study group and the non-dominant limb in the control group. There were no differences between the load on the non-operated limb in the study group and the load on the dominant limb in the control group. In the hemiepiphysiodesis group there were no significant differences between the mean total load on the treated and untreated limb after surgery. The median CoG sway area and path length in the group of patients after hemiphysiodesis and in the healthy control group did not differ. Conclusions: After hemiphysiodesis, the percentage load distribution did not differ between the operated and non-operated lower limb. Hemiepiphysiodesis allows for achieving balance similar to the healthy control group. Performing hemiepiphysiodesis allows for the improvement of balance parameters and load distribution in the lower limbs.
{"title":"Body Weight Distribution and Balance in Patients with Valgus or Varus Knee Deformity Treated with Hemiepiphysiodesis.","authors":"Paweł Leyko, Monika Zaborska, Agnieszka Walczak, Łukasz Tomczyk, Marcin Pelc, Aleksander Mnich, Igor Kowal, Piotr Morasiewicz","doi":"10.3390/jcm14238601","DOIUrl":"10.3390/jcm14238601","url":null,"abstract":"<p><p><b>Background:</b> Biomechanical disorders may result from joint deformities. The purpose of this prospective research was to assess total load distribution over the lower limbs and balance in individuals before and after an hemiepiphysiodesis procedure performed due to valgus or varus knee deformity. <b>Methods:</b> Thirty-five patients, mean age 12 years, who underwent hemiphysiodesis for valgus or varus deformity of the knee were evaluated in comparison to a healthy control group. In patients, the percentage distribution of weight-bearing capacity between the operated and unoperated limbs was analyzed before and after surgery. Balance was assessed based on CoG (center of gravity) sway area and the CoG path length. Results were collected using the FreeMED MAXI pedobarographic platform. <b>Results:</b> Before surgery, statistically significant lower load on the entire affected limb was noted compared to unaffected limb. The values of path of center of gravity improved statistically significantly after surgery, compared to the values before surgery. There were no differences in the load on the treated lower limb in the study group and the non-dominant limb in the control group. There were no differences between the load on the non-operated limb in the study group and the load on the dominant limb in the control group. In the hemiepiphysiodesis group there were no significant differences between the mean total load on the treated and untreated limb after surgery. The median CoG sway area and path length in the group of patients after hemiphysiodesis and in the healthy control group did not differ. <b>Conclusions:</b> After hemiphysiodesis, the percentage load distribution did not differ between the operated and non-operated lower limb. Hemiepiphysiodesis allows for achieving balance similar to the healthy control group. Performing hemiepiphysiodesis allows for the improvement of balance parameters and load distribution in the lower limbs.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 23","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12692848/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Accurately predicting difficult airways is essential to ensuring patient safety in anesthesiology and emergency medicine. However, traditional assessment tools often lack sufficient sensitivity and specificity, particularly in high-pressure or resource-limited settings. Artificial intelligence (AI) and machine learning (ML) have emerged as promising tools for enhancing airway assessment. Objective: This review evaluates the performance of AI- and ML-based models for predicting difficult airways and compares them with traditional clinical methods. The review also analyzes the models' methodological robustness, clinical applicability, and ethical considerations. Methods: A comprehensive literature search was conducted across PubMed, Web of Science, and Scopus to identify studies published between 2020 and 2025 that employed AI/ML models to predict difficult airways. Both original research and review articles were included. Key metrics, such as the area under the curve (AUC), sensitivity, and specificity, were extracted and compared. A qualitative analysis was performed to focus on dataset characteristics, validation strategies, model interpretability, and clinical relevance. Results: AI models demonstrated superior performance compared to traditional assessment tools. The MixMatch semi-supervised deep learning (DL) model achieved the highest performance (area under the curve [AUC] of 0.9435, sensitivity of 89.58%, and specificity of 90.13%). Models that used facial imaging combined with deep learning consistently outperformed those that relied solely on clinical parameters. However, methodological heterogeneity, a lack of standardized evaluation metrics, and limited population diversity impeded cross-study comparability. Few studies incorporated interpretability frameworks or addressed ethical challenges related to data privacy and algorithmic bias. Conclusions: AI and ML models have the potential to transform the assessment of difficult airways by improving diagnostic accuracy and enabling real-time clinical decision support.
背景:在麻醉学和急诊医学中,准确预测困难气道对确保患者安全至关重要。然而,传统的评估工具往往缺乏足够的敏感性和特异性,特别是在高压或资源有限的情况下。人工智能(AI)和机器学习(ML)已成为加强气道评估的有前途的工具。目的:评价基于AI和ml的气道困难预测模型的性能,并与传统临床方法进行比较。本综述还分析了模型的方法学稳健性、临床适用性和伦理考虑。方法:对PubMed、Web of Science和Scopus进行了全面的文献检索,以确定2020年至2025年间发表的使用AI/ML模型预测困难气道的研究。包括原始研究和评论文章。提取并比较关键指标,如曲线下面积(AUC)、敏感性和特异性。定性分析侧重于数据集特征、验证策略、模型可解释性和临床相关性。结果:与传统评估工具相比,人工智能模型表现出优越的性能。MixMatch半监督深度学习(DL)模型获得了最高的性能(曲线下面积[AUC]为0.9435,灵敏度为89.58%,特异性为90.13%)。使用面部成像与深度学习相结合的模型始终优于仅依赖临床参数的模型。然而,方法的异质性、缺乏标准化的评估指标和有限的人口多样性阻碍了交叉研究的可比性。很少有研究纳入可解释性框架或解决与数据隐私和算法偏见相关的伦理挑战。结论:人工智能和机器学习模型有可能通过提高诊断准确性和实现实时临床决策支持来改变对困难气道的评估。
{"title":"Artificial Intelligence for Predicting Difficult Airways: A Review.","authors":"Meruyert Alatau, Johann Bauer, Vitaliy Sazonov","doi":"10.3390/jcm14238600","DOIUrl":"10.3390/jcm14238600","url":null,"abstract":"<p><p><b>Background</b>: Accurately predicting difficult airways is essential to ensuring patient safety in anesthesiology and emergency medicine. However, traditional assessment tools often lack sufficient sensitivity and specificity, particularly in high-pressure or resource-limited settings. Artificial intelligence (AI) and machine learning (ML) have emerged as promising tools for enhancing airway assessment. <b>Objective</b>: This review evaluates the performance of AI- and ML-based models for predicting difficult airways and compares them with traditional clinical methods. The review also analyzes the models' methodological robustness, clinical applicability, and ethical considerations. <b>Methods</b>: A comprehensive literature search was conducted across PubMed, Web of Science, and Scopus to identify studies published between 2020 and 2025 that employed AI/ML models to predict difficult airways. Both original research and review articles were included. Key metrics, such as the area under the curve (AUC), sensitivity, and specificity, were extracted and compared. A qualitative analysis was performed to focus on dataset characteristics, validation strategies, model interpretability, and clinical relevance. <b>Results</b>: AI models demonstrated superior performance compared to traditional assessment tools. The MixMatch semi-supervised deep learning (DL) model achieved the highest performance (area under the curve [AUC] of 0.9435, sensitivity of 89.58%, and specificity of 90.13%). Models that used facial imaging combined with deep learning consistently outperformed those that relied solely on clinical parameters. However, methodological heterogeneity, a lack of standardized evaluation metrics, and limited population diversity impeded cross-study comparability. Few studies incorporated interpretability frameworks or addressed ethical challenges related to data privacy and algorithmic bias. <b>Conclusions</b>: AI and ML models have the potential to transform the assessment of difficult airways by improving diagnostic accuracy and enabling real-time clinical decision support.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 23","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12693205/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Hip fractures in older adults are sentinel events linked to high mortality and functional decline. Few studies have quantified long-term survival probabilities, standardized mortality ratios (SMRs), and risks of new nursing home admission alongside patient-related predictors. Methods: We retrospectively analyzed 355 patients aged ≥ 60 years who underwent hip fracture surgery at a general hospital in Japan (2020-2024). Primary outcomes were mortality and new nursing home admission. Survival probabilities and remaining life expectancy were estimated, and SMRs were calculated using age- and sex-matched national data. Cox regression identified independent predictors. Results: Mean age was 84 years; 76% were female. Mortality probabilities at 1, 2, and 3 years were 23%, 41%, and 60%, respectively; SMRs consistently exceeded 9. Median remaining life expectancy was 260 days. New nursing home admissions occurred in 42%, with cumulative probabilities of 16%, 27%, and 35% at 1, 2, and 3 years, respectively, showing a rapid rise within 9 months. Independent predictors of mortality were delayed surgery, higher Charlson Comorbidity Index, and low Geriatric Nutritional Risk Index. Older age and failure to regain ambulatory ability at 3 months predicted institutionalization. Conclusions: Older adults with hip fractures face persistently high mortality and institutionalization risks, comparable to advanced malignancies or neurodegenerative diseases. Surgical timing, comorbidities, nutrition, and functional recovery critically influence prognosis and should guide perioperative care and discharge planning.
{"title":"Time to Death and Nursing Home Admission in Older Adults with Hip Fracture: A Retrospective Cohort Study.","authors":"Yoichi Ito, Norio Yamamoto, Yosuke Tomita, Kotaro Adachi, Masaaki Konishi, Kunihiko Miyazawa","doi":"10.3390/jcm14238603","DOIUrl":"10.3390/jcm14238603","url":null,"abstract":"<p><p><b>Background</b>: Hip fractures in older adults are sentinel events linked to high mortality and functional decline. Few studies have quantified long-term survival probabilities, standardized mortality ratios (SMRs), and risks of new nursing home admission alongside patient-related predictors. <b>Methods</b>: We retrospectively analyzed 355 patients aged ≥ 60 years who underwent hip fracture surgery at a general hospital in Japan (2020-2024). Primary outcomes were mortality and new nursing home admission. Survival probabilities and remaining life expectancy were estimated, and SMRs were calculated using age- and sex-matched national data. Cox regression identified independent predictors. <b>Results</b>: Mean age was 84 years; 76% were female. Mortality probabilities at 1, 2, and 3 years were 23%, 41%, and 60%, respectively; SMRs consistently exceeded 9. Median remaining life expectancy was 260 days. New nursing home admissions occurred in 42%, with cumulative probabilities of 16%, 27%, and 35% at 1, 2, and 3 years, respectively, showing a rapid rise within 9 months. Independent predictors of mortality were delayed surgery, higher Charlson Comorbidity Index, and low Geriatric Nutritional Risk Index. Older age and failure to regain ambulatory ability at 3 months predicted institutionalization. <b>Conclusions</b>: Older adults with hip fractures face persistently high mortality and institutionalization risks, comparable to advanced malignancies or neurodegenerative diseases. Surgical timing, comorbidities, nutrition, and functional recovery critically influence prognosis and should guide perioperative care and discharge planning.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 23","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12693230/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cristina Rodriguez-Vidal, Nerea M Alday, María José Blanco Teijeiro, Manuel Bande
Background/Objectives: Posterior vitreous detachment (PVD) is an age-related physiological process, yet the clinical and biometric factors influencing its progression remain incompletely characterized in adults undergoing routine ophthalmic evaluation at a tertiary center. Characterizing expected vitreous patterns is essential for interpreting vitreoretinal interface changes in disease. This study aimed to identify independent clinical and biometric factors associated with more advanced PVD stages in adults without macular pathology. Methods: In this cross-sectional observational study, 340 eyes from 198 consecutive adults undergoing routine ophthalmological evaluation at a tertiary hospital (March 2022-April 2023) were analyzed. Eyes with current or past macular disease were excluded. Demographic variables, systemic comorbidities and ocular history were recorded. Axial length was measured using optical biometry IOLMaster 700 (Carl Zeiss Meditec, Jena, Germany). Vitreous status was assessed with 10-MHz B-scan ultrasonography and classified as no PVD, partial PVD or complete PVD. Analyses were performed at the eye level. Given its cross-sectional design, this study evaluates associations and cannot establish causal relationships. Bivariate comparisons examined associations between clinical variables and PVD grade. Multivariable modeling was conducted using a clustered generalized estimating equations (GEE) ordinal logit model as the primary analysis, and a secondary independent-eye ordinal logistic regression model was used to evaluate the proportional-odds assumption and model robustness. Results: Mean age was 55.6 ± 18.3 years, and 68.5% of eyes were from female participants. No PVD, partial PVD and complete PVD were present in 30.9%, 43.5% and 25.6% of eyes, respectively. In the primary GEE model, axial length (OR 1.35; p < 0.001), systemic hypertension (OR 7.13; p < 0.001), and prior cataract surgery (OR 2.13; p = 0.020) were independently associated with more advanced PVD stages. Age showed a modest but significant association with increasing PVD severity (OR 1.03; p = 0.012). Sex and diabetes mellitus were not associated with PVD grade. The independent-eye ordinal model yielded consistent effect directions. Conclusions: In adults without macular disease, more advanced PVD stages are independently associated with axial elongation, systemic hypertension, and previous cataract surgery, while age shows a mild but significant association. These findings provide clinically useful contextual reference information for interpreting vitreoretinal interface changes in health and disease. These associations should not be interpreted as causal due to the cross-sectional nature of the study.
背景/目的:玻璃体后脱离(PVD)是一种与年龄相关的生理过程,但在三级中心接受常规眼科检查的成人中,影响其进展的临床和生物特征因素尚未完全确定。表征预期的玻璃体模式对于解释疾病中玻璃体视网膜界面的变化至关重要。本研究旨在确定与成人无黄斑病变更晚期PVD相关的独立临床和生物特征因素。方法:对某三级医院(2022年3月- 2023年4月)连续198例成人常规眼科检查的340只眼进行横断面观察性研究。排除目前或过去有黄斑疾病的眼睛。记录人口统计学变量、全身合并症和眼部病史。使用光学生物测量仪IOLMaster 700(卡尔蔡司Meditec,耶拿,德国)测量轴向长度。采用10mhz b超评估玻璃体状态,并将玻璃体分为无PVD、部分PVD和完全PVD。分析在眼睛水平进行。鉴于其横断面设计,本研究评估关联,不能建立因果关系。双变量比较检验了临床变量与PVD分级之间的关系。采用聚类广义估计方程(GEE)有序逻辑模型进行多变量建模,并采用二级独立眼有序逻辑回归模型对比例-赔率假设和模型稳健性进行评估。结果:平均年龄为55.6±18.3岁,68.5%为女性。无PVD、部分PVD和完全PVD分别占30.9%、43.5%和25.6%。在初级GEE模型中,眼轴长度(OR 1.35; p < 0.001)、全身性高血压(OR 7.13; p < 0.001)和既往白内障手术(OR 2.13; p = 0.020)与更高级的PVD分期独立相关。年龄与PVD严重程度增加有轻微但显著的相关性(OR 1.03; p = 0.012)。性别和糖尿病与PVD分级无关。独立眼序模型的影响方向一致。结论:在没有黄斑疾病的成年人中,更高级的PVD阶段与轴伸长、全身性高血压和既往白内障手术独立相关,而年龄显示轻微但显著的关联。这些发现为解释健康和疾病中玻璃体视网膜界面的变化提供了临床有用的背景参考信息。由于研究的横断面性质,这些关联不应被解释为因果关系。
{"title":"Ultrasound-Based Assessment of Posterior Vitreous Detachment in Healthy Eyes: Clinical and Biometric Factors Associated with More Advanced PVD.","authors":"Cristina Rodriguez-Vidal, Nerea M Alday, María José Blanco Teijeiro, Manuel Bande","doi":"10.3390/jcm14238587","DOIUrl":"10.3390/jcm14238587","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Posterior vitreous detachment (PVD) is an age-related physiological process, yet the clinical and biometric factors influencing its progression remain incompletely characterized in adults undergoing routine ophthalmic evaluation at a tertiary center. Characterizing expected vitreous patterns is essential for interpreting vitreoretinal interface changes in disease. This study aimed to identify independent clinical and biometric factors associated with more advanced PVD stages in adults without macular pathology. <b>Methods</b>: In this cross-sectional observational study, 340 eyes from 198 consecutive adults undergoing routine ophthalmological evaluation at a tertiary hospital (March 2022-April 2023) were analyzed. Eyes with current or past macular disease were excluded. Demographic variables, systemic comorbidities and ocular history were recorded. Axial length was measured using optical biometry IOLMaster 700 (Carl Zeiss Meditec, Jena, Germany). Vitreous status was assessed with 10-MHz B-scan ultrasonography and classified as no PVD, partial PVD or complete PVD. Analyses were performed at the eye level. Given its cross-sectional design, this study evaluates associations and cannot establish causal relationships. Bivariate comparisons examined associations between clinical variables and PVD grade. Multivariable modeling was conducted using a clustered generalized estimating equations (GEE) ordinal logit model as the primary analysis, and a secondary independent-eye ordinal logistic regression model was used to evaluate the proportional-odds assumption and model robustness. <b>Results</b>: Mean age was 55.6 ± 18.3 years, and 68.5% of eyes were from female participants. No PVD, partial PVD and complete PVD were present in 30.9%, 43.5% and 25.6% of eyes, respectively. In the primary GEE model, axial length (OR 1.35; <i>p</i> < 0.001), systemic hypertension (OR 7.13; <i>p</i> < 0.001), and prior cataract surgery (OR 2.13; <i>p</i> = 0.020) were independently associated with more advanced PVD stages. Age showed a modest but significant association with increasing PVD severity (OR 1.03; <i>p</i> = 0.012). Sex and diabetes mellitus were not associated with PVD grade. The independent-eye ordinal model yielded consistent effect directions. <b>Conclusions</b>: In adults without macular disease, more advanced PVD stages are independently associated with axial elongation, systemic hypertension, and previous cataract surgery, while age shows a mild but significant association. These findings provide clinically useful contextual reference information for interpreting vitreoretinal interface changes in health and disease. These associations should not be interpreted as causal due to the cross-sectional nature of the study.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 23","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12693443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sema Kaymaz-Tahra, Salih Ozguven, Aysegul Avcu, Nuh Filizoglu, Ali Ugur Unal, Tunc Ones, Tanju Yusuf Erdil, Fatma Alibaz-Oner, Haner Direskeneli
Background/Objectives: Takayasu's arteritis (TAK) is an inflammatory vascular disease, but atherosclerotic mechanisms may also contribute to vascular injury in TAK. This study aimed to evaluate the clinical and imaging characteristics of TAK patients with and without iliofemoral artery involvement on FDG-PET/CT, focusing on the association with classical atherosclerotic risk factors. Methods: Patients fulfilling the 1990 ACR classification criteria for TAK who underwent FDG-PET/CT imaging during follow-up were retrospectively analyzed. Demographic, clinical, and laboratory data were recorded, including traditional cardiovascular risk factors: diabetes, hypertension, hyperlipidemia, smoking, obesity (BMI ≥ 30 kg/m2), and family history of cardiovascular disease. PET vascular activity score (PETVAS) and visual analysis were used to assess vascular inflammation. Results: PET/CT scans of 77 TAK patients (F/M = 63/14) were evaluated. The mean age was 43.0 ± 12.9 years, and the mean disease duration was 120.1 ± 88.8 months. Iliofemoral artery involvement was observed in nine (12%) patients. Compared to those without such involvement, these patients were older (52.5 ± 17.4 vs. 41.3 ± 12.1 years, p = 0.098), more frequently male (44% vs. 6%, p = 0.015), and had higher CRP levels (38.5 mg/L vs. 10.7 mg/L, p = 0.026). Smoking (77% vs. 40%, p = 0.045) and chronic kidney disease (22% vs. 4%, p = 0.046) were also more prevalent. PET activity according to visual analysis was higher among those with iliofemoral involvement (67% vs. 27%, p = 0.015). In multivariate analysis, older age (OR = 1.07, p = 0.044) and male sex (OR = 6.68, p = 0.039) were independently associated with iliofemoral artery involvement. Conclusions: Iliofemoral artery involvement on PET/CT in TAK patients was associated with traditional atherosclerotic risk factors-particularly older age, male sex and smoking. These findings suggest that atherosclerotic mechanisms may coexist with or amplify vascular inflammation in TAK. Aggressive management of cardiovascular risk factors should therefore be emphasized in this subgroup of TAK patients.
{"title":"Involvement of Iliofemoral Arteries in PET/CT Is Associated with Atherosclerotic Risk Factors in Takayasu's Arteritis.","authors":"Sema Kaymaz-Tahra, Salih Ozguven, Aysegul Avcu, Nuh Filizoglu, Ali Ugur Unal, Tunc Ones, Tanju Yusuf Erdil, Fatma Alibaz-Oner, Haner Direskeneli","doi":"10.3390/jcm14238607","DOIUrl":"10.3390/jcm14238607","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Takayasu's arteritis (TAK) is an inflammatory vascular disease, but atherosclerotic mechanisms may also contribute to vascular injury in TAK. This study aimed to evaluate the clinical and imaging characteristics of TAK patients with and without iliofemoral artery involvement on FDG-PET/CT, focusing on the association with classical atherosclerotic risk factors. <b>Methods</b>: Patients fulfilling the 1990 ACR classification criteria for TAK who underwent FDG-PET/CT imaging during follow-up were retrospectively analyzed. Demographic, clinical, and laboratory data were recorded, including traditional cardiovascular risk factors: diabetes, hypertension, hyperlipidemia, smoking, obesity (BMI ≥ 30 kg/m<sup>2</sup>), and family history of cardiovascular disease. PET vascular activity score (PETVAS) and visual analysis were used to assess vascular inflammation. <b>Results</b>: PET/CT scans of 77 TAK patients (F/M = 63/14) were evaluated. The mean age was 43.0 ± 12.9 years, and the mean disease duration was 120.1 ± 88.8 months. Iliofemoral artery involvement was observed in nine (12%) patients. Compared to those without such involvement, these patients were older (52.5 ± 17.4 vs. 41.3 ± 12.1 years, <i>p</i> = 0.098), more frequently male (44% vs. 6%, <i>p</i> = 0.015), and had higher CRP levels (38.5 mg/L vs. 10.7 mg/L, <i>p</i> = 0.026). Smoking (77% vs. 40%, <i>p</i> = 0.045) and chronic kidney disease (22% vs. 4%, <i>p</i> = 0.046) were also more prevalent. PET activity according to visual analysis was higher among those with iliofemoral involvement (67% vs. 27%, <i>p</i> = 0.015). In multivariate analysis, older age (OR = 1.07, <i>p</i> = 0.044) and male sex (OR = 6.68, <i>p</i> = 0.039) were independently associated with iliofemoral artery involvement. <b>Conclusions</b>: Iliofemoral artery involvement on PET/CT in TAK patients was associated with traditional atherosclerotic risk factors-particularly older age, male sex and smoking. These findings suggest that atherosclerotic mechanisms may coexist with or amplify vascular inflammation in TAK. Aggressive management of cardiovascular risk factors should therefore be emphasized in this subgroup of TAK patients.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 23","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12692745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pinar Bambul Heck, Andreas Schüttler, Alfred Hager, Masamichi Ono, Jürgen Hörer, Peter Ewert, Oktay Tutarel
Background/Objectives: Data on the long-term outcomes of hypoplastic left heart syndrome (HLHS) patients compared to other single-ventricle patients reaching adolescence after Fontan surgery is limited. This study analyzes the outcomes of HLHS patients compared to non-HLHS patients following total cavopulmonary connection (TCPC) from the same era at a large single center. Methods: This study included patients aged ≥ 12 years at the last follow-up who underwent TCPC surgery between 05/2001 and 12/2009, with follow-up data available from 05/2012 to 01/2024. The primary endpoint (Fontan-specific major adverse cardiovascular events, MACEs) included all-cause death, cardiac transplantation or listing, heart failure hospitalizations, ventricular arrhythmias, third-degree AV block, or resuscitation. Results: A total of 130 patients were included, with 39 (30.0%) having HLHS. Among non-HLHS patients, 18 (13.8%) had a systemic right ventricle, and 73 (56.2%) had a systemic left ventricle. The mean age at the last follow-up was 18.6 ± 3.2 years, with no significant age difference between groups (p = 0.195). HLHS patients experienced significantly more MACEs (p = 0.019), had reduced ventricular function (p = 0.009), and exhibited higher NT-proBNP levels (p = 0.004) compared to non-HLHS patients. Conclusions: While long-term outcomes for adolescents with TCPC are generally encouraging, HLHS patients are at higher risk of adverse cardiovascular events. These findings highlight the need for targeted follow-up and interventions to improve long-term prognosis in this high-risk group.
{"title":"Outcome of Fontan Patients After Reaching Adolescence: The Impact of Hypoplastic Left Heart Syndrome.","authors":"Pinar Bambul Heck, Andreas Schüttler, Alfred Hager, Masamichi Ono, Jürgen Hörer, Peter Ewert, Oktay Tutarel","doi":"10.3390/jcm14238611","DOIUrl":"10.3390/jcm14238611","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Data on the long-term outcomes of hypoplastic left heart syndrome (HLHS) patients compared to other single-ventricle patients reaching adolescence after Fontan surgery is limited. This study analyzes the outcomes of HLHS patients compared to non-HLHS patients following total cavopulmonary connection (TCPC) from the same era at a large single center. <b>Methods</b>: This study included patients aged ≥ 12 years at the last follow-up who underwent TCPC surgery between 05/2001 and 12/2009, with follow-up data available from 05/2012 to 01/2024. The primary endpoint (Fontan-specific major adverse cardiovascular events, MACEs) included all-cause death, cardiac transplantation or listing, heart failure hospitalizations, ventricular arrhythmias, third-degree AV block, or resuscitation. <b>Results</b>: A total of 130 patients were included, with 39 (30.0%) having HLHS. Among non-HLHS patients, 18 (13.8%) had a systemic right ventricle, and 73 (56.2%) had a systemic left ventricle. The mean age at the last follow-up was 18.6 ± 3.2 years, with no significant age difference between groups (<i>p</i> = 0.195). HLHS patients experienced significantly more MACEs (<i>p</i> = 0.019), had reduced ventricular function (<i>p</i> = 0.009), and exhibited higher NT-proBNP levels (<i>p</i> = 0.004) compared to non-HLHS patients. <b>Conclusions</b>: While long-term outcomes for adolescents with TCPC are generally encouraging, HLHS patients are at higher risk of adverse cardiovascular events. These findings highlight the need for targeted follow-up and interventions to improve long-term prognosis in this high-risk group.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 23","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12693486/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Systemic inflammation plays a pivotal role in heart failure (HF) progression, yet no meta-analysis has synthesized prospective cohort data on interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and neutrophil-to-lymphocyte ratio (NLR) as prognostic biomarkers. Objectives: To quantify the independent prognostic value of IL-6, hs-CRP, and NLR for mortality and HF-related outcomes across HF phenotypes. Methods: Following PRISMA and MOOSE guidelines, we searched PubMed, Embase, Scopus, Web of Science, and CENTRAL from January 2014 to October 2025 for prospective cohorts reporting adjusted hazard ratios (HRs). Random-effects meta-analysis pooled HRs; heterogeneity was assessed via I2 statistic, with subgroup and sensitivity analyses for robustness. Quality was evaluated using Newcastle-Ottawa Scale (NOS) and GRADE. Results: Thirteen cohorts (n ≈ 19,000) were included. Elevated IL-6 (five studies) was associated with increased all-cause mortality and composite outcomes (low-moderate heterogeneity, I2 < 35%). hs-CRP (five studies) showed similar prognostic strength, with trajectories amplifying risk. NLR (three studies) independently predicted adverse events with negligible heterogeneity. Associations persisted across HFrEF and HFpEF, acute/chronic settings, and geographic regions, independent of natriuretic peptides and comorbidities (NOS median 8/9; GRADE moderate-to-high). Conclusions: IL-6, hs-CRP, and NLR are robust, independent prognostic biomarkers in HF, supporting their integration into clinical risk stratification and inflammation-targeted therapies. PROSPERO: CRD420251207035.
背景:全身性炎症在心力衰竭(HF)进展中起着关键作用,但没有meta分析综合了白细胞介素-6 (IL-6)、高敏c反应蛋白(hs-CRP)和中性粒细胞与淋巴细胞比率(NLR)作为预后生物标志物的前瞻性队列数据。目的:量化不同HF表型中IL-6、hs-CRP和NLR对死亡率和HF相关结局的独立预后价值。方法:根据PRISMA和MOOSE指南,我们从2014年1月至2025年10月检索PubMed、Embase、Scopus、Web of Science和CENTRAL,寻找报告调整风险比(hr)的前瞻性队列。随机效应荟萃分析汇集了hr;通过I2统计量评估异质性,并进行亚组分析和敏感性分析。采用纽卡斯尔-渥太华量表(NOS)和GRADE评价质量。结果:纳入13个队列(n≈19,000)。升高的IL-6(5项研究)与全因死亡率和综合结果增加相关(低-中度异质性,I2 < 35%)。hs-CRP(五项研究)显示出类似的预后强度,其轨迹放大了风险。NLR(三项研究)独立预测不良事件,异质性可忽略不计。HFrEF和HFpEF、急性/慢性情况和地理区域的相关性持续存在,与利钠肽和合合症无关(NOS中位数为8/9;GRADE中至高)。结论:IL-6、hs-CRP和NLR是心衰中可靠的、独立的预后生物标志物,支持它们整合到临床风险分层和炎症靶向治疗中。普洛斯彼罗:CRD420251207035。
{"title":"Systemic Inflammatory Biomarkers (Interleukin-6, High-Sensitivity C-Reactive Protein, and Neutrophil-to-Lymphocyte Ratio) and Prognosis in Heart Failure: A Meta-Analysis of Prospective Cohort Studies.","authors":"Ana-Maria Pah, Stefania Serban, Diana-Maria Mateescu, Ioana-Georgiana Cotet, Camelia-Oana Muresan, Adrian-Cosmin Ilie, Florina Buleu, Maria-Laura Craciun, Simina Crisan, Adina Avram","doi":"10.3390/jcm14238610","DOIUrl":"10.3390/jcm14238610","url":null,"abstract":"<p><p><b>Background:</b> Systemic inflammation plays a pivotal role in heart failure (HF) progression, yet no meta-analysis has synthesized prospective cohort data on interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and neutrophil-to-lymphocyte ratio (NLR) as prognostic biomarkers. <b>Objectives:</b> To quantify the independent prognostic value of IL-6, hs-CRP, and NLR for mortality and HF-related outcomes across HF phenotypes. <b>Methods:</b> Following PRISMA and MOOSE guidelines, we searched PubMed, Embase, Scopus, Web of Science, and CENTRAL from January 2014 to October 2025 for prospective cohorts reporting adjusted hazard ratios (HRs). Random-effects meta-analysis pooled HRs; heterogeneity was assessed via I<sup>2</sup> statistic, with subgroup and sensitivity analyses for robustness. Quality was evaluated using Newcastle-Ottawa Scale (NOS) and GRADE. <b>Results:</b> Thirteen cohorts (<i>n</i> ≈ 19,000) were included. Elevated IL-6 (five studies) was associated with increased all-cause mortality and composite outcomes (low-moderate heterogeneity, I<sup>2</sup> < 35%). hs-CRP (five studies) showed similar prognostic strength, with trajectories amplifying risk. NLR (three studies) independently predicted adverse events with negligible heterogeneity. Associations persisted across HFrEF and HFpEF, acute/chronic settings, and geographic regions, independent of natriuretic peptides and comorbidities (NOS median 8/9; GRADE moderate-to-high). <b>Conclusions:</b> IL-6, hs-CRP, and NLR are robust, independent prognostic biomarkers in HF, supporting their integration into clinical risk stratification and inflammation-targeted therapies. PROSPERO: CRD420251207035.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 23","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12692851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
As surgeries using multifocal intraocular lenses (IOLs) to correct both cataracts and presbyopia have become common, it has become essential for clinicians to understand their basic optical characteristics to select the optimal lens for their patients. However, there are relatively few review articles on optics that are directly useful to clinicians who perform surgery on patients. In this paper, we systematically review fundamental concepts, from the basic properties of light, geometric optics, and Gaussian approximation to lens performance metrics like the point spread function and modulation transfer function (MTF), and the clinical implications of spherical and chromatic aberrations. Based on these principles, the mechanisms of major multifocal technologies are explained. We also explore the refractive extended depth of focus lenses, which expand the range of focus by precisely controlling higher-order spherical aberrations. In contrast, diffractive lenses use diffractive kinoforms to split light into multiple foci, and they may also leverage higher diffraction orders to correct chromatic aberration. However, this multifocality involves an optical compromise, often resulting in a reduced overall MTF compared to monofocal IOLs and photic phenomena such as glare and halo. In conclusion, while multifocal IOLs are groundbreaking technology that significantly enhances quality of life by reducing spectacle dependence, this comes at the cost of sacrificing optimal image quality. Therefore, a thorough understanding of these optical principles by ophthalmologists is crucial for selecting the optimal lens according to each patient's ocular condition and for managing postoperative outcomes.
{"title":"Basic Optics Underlying Current Intraocular Lenses.","authors":"Yengwoo Son, Seung Pil Bang, Choul Yong Park","doi":"10.3390/jcm14238608","DOIUrl":"10.3390/jcm14238608","url":null,"abstract":"<p><p>As surgeries using multifocal intraocular lenses (IOLs) to correct both cataracts and presbyopia have become common, it has become essential for clinicians to understand their basic optical characteristics to select the optimal lens for their patients. However, there are relatively few review articles on optics that are directly useful to clinicians who perform surgery on patients. In this paper, we systematically review fundamental concepts, from the basic properties of light, geometric optics, and Gaussian approximation to lens performance metrics like the point spread function and modulation transfer function (MTF), and the clinical implications of spherical and chromatic aberrations. Based on these principles, the mechanisms of major multifocal technologies are explained. We also explore the refractive extended depth of focus lenses, which expand the range of focus by precisely controlling higher-order spherical aberrations. In contrast, diffractive lenses use diffractive kinoforms to split light into multiple foci, and they may also leverage higher diffraction orders to correct chromatic aberration. However, this multifocality involves an optical compromise, often resulting in a reduced overall MTF compared to monofocal IOLs and photic phenomena such as glare and halo. In conclusion, while multifocal IOLs are groundbreaking technology that significantly enhances quality of life by reducing spectacle dependence, this comes at the cost of sacrificing optimal image quality. Therefore, a thorough understanding of these optical principles by ophthalmologists is crucial for selecting the optimal lens according to each patient's ocular condition and for managing postoperative outcomes.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 23","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12693475/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Corinna Schneider, Melánia Pozsgai, Csongor Németh, Zita Battyáni, Zsuzsanna Lengyel
Background/Objectives: With the increasing use of immune checkpoint inhibitors (ICIs), their administration in pregnant patients is expected to become more frequent. Although immunotherapy has transformed melanoma treatment, its use during pregnancy remains complex and controversial. Methods: We present the case of a young female patient diagnosed with advanced melanoma in whom combination ICI therapy was initiated. Results: During maintenance nivolumab treatment, a routine staging CT scan revealed an incidental pregnancy. Immunotherapy was discontinued upon pregnancy detection. The pregnancy proceeded without significant complications related to melanoma or the immunotherapy. During follow-up, the patient remained in remission and delivered a healthy male infant at 38 weeks of gestation. Conclusions: The most frequently reported side effects of ICIs during in utero exposure include fetal growth restriction, premature delivery, fetal distress syndrome, and occasional congenital abnormalities such as hypothyroidism and hand malformations. While existing evidence highlights potential risks, isolated case reports-including the present case-demonstrate that favorable pregnancy and neonatal outcomes are possible with careful monitoring and multidisciplinary care. Given the limited literature on ICI use during pregnancy, our case adds meaningful clinical insights to the field and underscores the need for further research and data collection to establish definitive guidelines, with an emphasis on individualized risk assessment and multidisciplinary care.
{"title":"A Healthy Pregnancy During Treatment of Metastatic Melanoma with Immune Checkpoint Inhibitors: A Case Report.","authors":"Corinna Schneider, Melánia Pozsgai, Csongor Németh, Zita Battyáni, Zsuzsanna Lengyel","doi":"10.3390/jcm14238591","DOIUrl":"10.3390/jcm14238591","url":null,"abstract":"<p><p><b>Background/Objectives</b>: With the increasing use of immune checkpoint inhibitors (ICIs), their administration in pregnant patients is expected to become more frequent. Although immunotherapy has transformed melanoma treatment, its use during pregnancy remains complex and controversial. <b>Methods</b>: We present the case of a young female patient diagnosed with advanced melanoma in whom combination ICI therapy was initiated. <b>Results</b>: During maintenance nivolumab treatment, a routine staging CT scan revealed an incidental pregnancy. Immunotherapy was discontinued upon pregnancy detection. The pregnancy proceeded without significant complications related to melanoma or the immunotherapy. During follow-up, the patient remained in remission and delivered a healthy male infant at 38 weeks of gestation. <b>Conclusions</b>: The most frequently reported side effects of ICIs during in utero exposure include fetal growth restriction, premature delivery, fetal distress syndrome, and occasional congenital abnormalities such as hypothyroidism and hand malformations. While existing evidence highlights potential risks, isolated case reports-including the present case-demonstrate that favorable pregnancy and neonatal outcomes are possible with careful monitoring and multidisciplinary care. Given the limited literature on ICI use during pregnancy, our case adds meaningful clinical insights to the field and underscores the need for further research and data collection to establish definitive guidelines, with an emphasis on individualized risk assessment and multidisciplinary care.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 23","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12692992/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}